Compound class:
Synthetic organic
Comment: SX682 is a selective and reversible antagonist (negative allosteric modulator) of the C-X-C motif chemokine receptors CXCR1 and CXCR2. It is orally bioavailable and is being investigated for potential anti-inflammatory and antineoplastic activities. It was developed by Syntrix Pharmaceuticals. The chemical structure presented here was obtained from the NIH's NCI drug Dictionary
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
[2-[[5-[(4-fluorophenyl)carbamoyl]pyrimidin-2-yl]sulfanylmethyl]-4-(trifluoromethoxy)phenyl]boronic acid |
Database Links ![]() |
|
CAS Registry No. | 1648843-04-2 (source: PubChem) |
GtoPdb PubChem SID | 381118875 |
PubChem CID | 90467234 |
Search Google for chemical match using the InChIKey | SDUDZBCEHIZMFZ-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | SDUDZBCEHIZMFZ |
UniChem Compound Search for chemical match using the InChIKey | SDUDZBCEHIZMFZ-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | SDUDZBCEHIZMFZ-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
SX-682 (links to external site)
Cat. No. HY-119339 |